Background. Immediate, implant-only breast reconstruction is traditionally discouraged in patients who receive radiation. It is not clear whether this widely recognized mantra of breast reconstruction is observed in practice. The purpose of this study was to evaluate immediate reconstruction trends and practices in patients who have undergone mastectomy and radiation therapy. Methods. Female patients with unilateral breast cancer who required radiation in addition to mastectomy were extracted from the Surveillance, Epidemiology, and End Results (SEER) database from 2000 through 2010. Patients who underwent immediate reconstruction were identified and analyzed. Univariate and logistic regression analyses were performed to study the relationship between reconstructive method and patient demographic and oncologic characteristics. Results. A total of 5,481 female patients who underwent radiation and breast reconstruction were included for analysis. Postmastectomy radiation therapy was performed in 98.3 % of the patients. The immediate breast reconstruction rate among patients requiring radiation increased from 13.6 to 25.1 %. The percentage of reconstructed patients who had implant-only reconstruction increased from 27 to 52 % (p \ 0.001) with a decrease in tissue-only reconstruction from 56 to 32 % (p \ 0.001). In regression analysis, the odds of implant reconstruction over autologous reconstruction increased each year by an odds ratio of 1.13 (95 % CI 1.10-1.15).
1
Immediate, implant-only breast reconstruction traditionally is discouraged in patients who are to receive radiation therapy because of the concern for adverse tissue changes associated with radiation. [2] [3] [4] [5] [6] These adverse tissue effects include tissue fibrosis, decreased vascularity, and increased tissue edema, ultimately portending a higher risk for postoperative morbidity, including wound dehiscence, tissue expander exposure, and/or infection. [4] [5] [6] [7] The significance of these tissue effects is underscored by multiple single-center studies with findings of relatively substantial morbidity associated with immediate implantonly breast reconstruction in the setting of postmastectomy radiation. Christante et al. showed that implant removal was required in more than 30 % of patients who underwent immediate breast reconstruction followed by postmastectomy radiation therapy. 4 Hirsch et al. similarly reported a 22.3 % major complication rate in patients who undergo immediate tissue expander reconstruction followed by radiation. 6 Despite these findings, multiple studies in recent years have endorsed favorable outcomes of implant reconstruction of the radiated breast; this suggests that there may be a growing acceptance of this reconstructive approach. [8] [9] [10] Implant reconstructions do provide distinct advantages, including shorter operative times, less technically demanding operations, the avoidance of donor sites, and potential for shorter recovery relative to flap alternatives. These reasons in addition to better reimbursement for implant reconstruction have likely contributed to its overall increased use for breast reconstruction.
Current national reconstruction practices and trends specifically in the more challenging radiated patient are less well known. To gain a better understanding of the reconstructive management of patients requiring postmastectomy radiation therapy, this study aims to describe national trends for reconstruction of the radiated breast and to assess factors that influence the reconstructive methods used.
METHODS

Data
Population-level de-identified data were extracted from the SEER cancer database (November 2012 submission) for the years 2000 through 2010. The SEER database collects patient-level data for all index malignant tumors in 18 cancer registries across the United States and captures 28 % of the nation's population. 11 This database is regarded as nationally representative and contains detailed demographic, socioeconomic, oncologic, and therapeutic information. To ensure data accuracy, chart abstracters undergo extensive training. Malignant tumors are encoded by use of the ninth revision of the International Classification of Diseases for Oncology. In addition to demographic and oncologic data, the SEER database has recently included specific data on multiple breast reconstruction techniques. Data on reconstruction in this database are limited to procedures performed within 4 months of mastectomy. Thus, data on delayed reconstructions performed greater than 4 months after mastectomy were not available.
Patient Inclusion/Exclusion
Female patients, ages 18-80 years, from 2000 to 2010 with American Joint Committee on Cancer (AJCC) stage I to III breast cancer were eligible for selection. Patients with a diagnosis of unilateral, ductal, and/or lobular carcinoma (histology codes: 8500, 8501, 8503, 8504, 8520, 8521, 8522, 8523, 8524) who had undergone unilateral mastectomy (surgery codes 30, 40-75, 80) with radiation and specified reconstruction were included. Only patients with new primary breast cancers were included. Patients in the database without a specifically defined method of breast reconstruction were excluded from the subgroup analyses involving method of reconstruction.
Statistical Analysis
Categorical demographic characteristics accounted for in our analysis included age (18-35, 36-55, 56-70 , and 71-80 years old), race (white, black, other, unknown), and year of diagnosis (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) . Categorical oncologic variables included tumor stage (I, II, III), tumor size (\1, 1-1.9, 2-4.9, 5? cm, unknown), tumor grade (I, II, III, IV), node status (positive, negative, unknown), ER status (positive, negative, unknown/borderline), PR status (positive, negative, unknown/borderline), radiation (yes, no, unknown), and whether this was a first primary (yes or no). Associations between characteristics and type of reconstruction were determined using Chi square tests of independence for categorical associations and KruskalWallis tests for continuous associations. A multinomial logistic regression model was developed to determine the odds of choosing implant alone over tissue reconstruction and combined reconstruction over tissue reconstruction controlling for personal and tumor characteristics. Independent variables with a p \ 0.2 in the univariate analysis were initially fit into a multivariate model and then using backward selection, only variables with a p \ 0.2 were retained in the adjusted multivariate model. All statistical analyses were performed with SAS version 9.3 (SAS Institute Inc.). Tests were deemed statistically significant at the level of 0.05.
RESULTS
Population Characteristics and Reconstruction Trends
A total of 40,568 patients who underwent mastectomy and radiation were identified over the 11-year period. Reconstruction was performed in 6,875 patients (16.9 %). The reconstruction rate in radiated patients increased from 13.6 % in 2000 to 25.1 % in 2010 (Fig. 1 ). Of these women with reconstruction, 5,481 (13.5 %) patients had specific reconstruction surgery type information (implant, tissue, or both), and this study focuses on this sample as shown in Table 1 . A majority of the reconstructed patient population (88.6 %) fell within an age range from 36 to 70 years. 2,760 patients (50.4 %) had stage III breast cancers, with 4,444 patients (81.1 %) had node-positive disease. A total of 5,390 patients (98.3 %) had postmastectomy radiation therapy. The demographic breakdown and tumor characteristics related to reconstruction method are outlined in Table 2 . The percentage of reconstructed patients who were reconstructed with implants only increased from 29 % in 2000 to 52 % in 2010 (Fig. 2) ; over the same time period the percentage of reconstructed patients reconstructed with autologous tissue decreased from 55 to 32 %. The use of combined autologous tissue with implant techniques remained relatively consistent with some fluctuations in the rate which ranged from 8 to 19 %.
Association Between Demographic and Tumor Characteristics and Reconstruction Method
Univariate analysis showed a statistically significant difference in the percentage of patients who underwent implant, autologous, or combined reconstruction when stratified by race, year of diagnosis, tumor stage, tumor size, ER, and PR status ( Table 2 ). In a multivariate multinomial model, African American patients were significantly less likely to receive implant reconstruction than autologous Table 3 ). From 2001 to 2010, there was an increasing trend in the odds of implantbased reconstruction over autologous reconstruction; on average each year increased the odds of implant reconstruction with an odds ratio of 1.13 (95 % CI 1.10-1.15).
DISCUSSION
In this study, we describe the reconstructive trends specifically in breast cancer patients who have received radiation therapy. By using the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database, we are able to obtain data from a population representative of the entire United States. The SEER database reports breast reconstruction method (autologous, implant, or combined) within a 4-month period after initial mastectomy. This database has been used by previous studies to evaluate trends in immediate breast reconstruction; however, these studies have not previously evaluated differences in breast reconstruction technique based on patient receipt of radiation therapy. [12] [13] [14] We found that overall, 17 % of patients who had undergone radiation were reconstructed by either autologous, implant, or combined techniques within 4 months of their mastectomy, between 2000 and 2010. However, there has been a nearly twofold increase in the overall reconstruction rate of radiated patients, rising from 14 % in 2000 to 25 % in 2010. This may represent a growing level of comfort among plastic surgeons with reconstruction in the setting of postmastectomy radiation therapy or may just reflect the overall increased frequency of immediate breast reconstruction. Previous studies using the SEER database have confirmed an increasing trend in immediate breast reconstruction among all patients independent of radiation status. [12] [13] [14] Using the Nationwide Inpatient Sample, Albornoz et al. have shown that implant reconstruction rates increased by 11 % annually from 1998 to 2008 and that overall reconstruction rates increase by 5 % annually. 15 Similar findings of increased implant use were reported in a recent study by Jagsi et al. using the MarketScan database. again be part of a broader trend of increased implant-based reconstruction in all mastectomy patients. 1, [15] [16] [17] [18] A review of the literature suggests that surgeons are more willing to perform immediate implant-based reconstruction in radiated patients. After evaluating a series of 12 patients with bilateral tissue expander/implant reconstruction with subsequent unilateral postmastectomy radiation therapy, McCarthy et al. found that despite higher rates of capsular contracture of the radiated breast, aesthetic results were good to excellent and patient satisfaction was high. 9 They concluded that immediate tissue expander/implant reconstructions are an acceptable option for patients requiring postmastectomy radiation therapy. More recently Sbitany et al. in evaluating the morbidity associated with immediate implant reconstruction in 580 patients undergoing nipple-sparing mastectomy with or without radiation found significantly higher infections (21.6 vs. 13.1 %) and expander/implant losses (18.75 vs. 5.1 %) in radiated patients. 10 They concluded that immediate implant reconstruction in the setting of pre-or postmastectomy radiation is a safe operation. Complications associated with implant reconstruction of the radiated breast cannot be overlooked. Our systematic review of the literature evaluating outcomes of implant-based reconstruction in the setting of postmastectomy radiation therapy found an overall major complication rate of 39 % with rates ranging from 2 to 94 %. 4, 5, 8, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Pooled data from included studies showed a 20 % reconstruction failure rate. 19 These findings indicate that although successful reconstruction can be achieved with implants alone in radiated patients, a significant number of complications and failures can be expected. By using a validated instrument to learn from the patient's perspective, Albornoz et al. found that postmastectomy radiation therapy has a negative impact on quality of life and satisfaction following implant-based reconstruction. 30 With these significant complication rates and less than ideal quality of life measures, we would caution against this approach to reconstruction of patients with planned radiation.
A reality of breast cancer treatment and reconstruction is that in a substantial number of cases, some of the information needed for treatment may not be available prior to the mastectomy. Because final pathology results often are not available for several days after the mastectomy, the need for radiation based on lymph node status or margins may not be known at the time of an immediate breast reconstruction. As such patients may undergo immediate reconstruction following their mastectomy only to find out that radiation therapy is needed weeks later. In an attempt to address this problem in this subset of patients undergoing mastectomy with the possible need for radiation, Kronowitz et al. introduced the concept of delayedimmediate breast reconstruction. 31 Tissue expanders are placed at the time of mastectomy and filled with saline to expand the skin envelope, which allows time for review of permanent sections with decisions on the need for radiation. Patients not requiring radiation proceed with immediate implant reconstruction and patients requiring radiation are allowed to complete radiation with the tissue expander in place, prior to further delayed reconstruction (possibly with implants). A problem with this strategy is that as many as 32 % of breasts expanders exposed to radiation fail during the reconstruction process and require explantation. 26 An alternative approach that allows for a better determination of the need for postmastectomy radiation prior to mastectomy and immediate reconstruction is the premastectomy sentinel lymph node biopsy (PM-SLNB). 32 This is the technique employed at our institution wherein the sentinel lymph node biopsy is performed days to weeks in advance of the mastectomy. Patients who have a positive sentinel lymph node will likely require radiation, and therefore are not offered immediate breast reconstruction with implants or autologous tissue.
A concomitant decrease in immediate autologous reconstructions in the radiated patient population also was observed. Although the SEER database collects information on breast reconstruction up to 4 months after the initial mastectomy, it is unlikely that it captures delayed reconstructions. Delayed reconstructions are typically performed after completion of adjuvant chemotherapy and radiation, which in combination could span a 6-month period after mastectomy and falls out of the collection period for the database. A preference for delayed autologous reconstruction in the radiated breast would be consistent with traditional recommendations for reconstruction in this patient population. 4 The approach of delayed autologous reconstruction avoids exposure of flaps to the untoward effects of radiation. The magnitude of the effect of present day radiation on flaps is a subject of debate, with some suggestions that favorable outcomes can be achieved with immediate autologous reconstruction followed by radiation. 33 Race and ethnicity had an impact on the reconstructive method employed. Relative to Caucasians, African American patients in our study had significantly less odds of receiving implant reconstruction in the setting of radiation. Other studies have shown that African American patients are more likely to receive flap reconstruction as opposed to implant reconstruction compared with Caucasian patients. 34, 35 Some reasons cited for this preference for flaps by African American patients include challenges associated with multiple clinic visits required for tissue expander reconstruction in patients who may live further from health care centers and a possible distrust of the traditional health care system leading to heightened concerns over the safety of implants. 34 Delving deeper into African American patient perspectives on the choice for type of reconstruction, a qualitative study by Rubin et al. found that there is a spiritual/cultural influence on decisions made by African American women. 36 Some patients in the study had reservations about breast implants, expressing a preference to use ''what God has given'' for reconstruction. Understanding that barriers to access exist, the reason for the observed differences in reconstruction strategy in this current study are likely multifactorial.
This study has a number of limitations. We are only able to report on immediate breast reconstruction rates and methods based on the unique features of the SEER database. Information on delayed reconstruction beyond 4 months after mastectomy would be important to gain a full appreciation of reconstruction trends in the broader community. Decisions made on reconstruction type may be influenced by surgeon preference and financial consideration for reimbursement. These factors unfortunately cannot be evaluated using the SEER database. Also not included in the database are patient factors, such as obesity, smoking history, previous surgical procedures that preclude autologous options, and patient preferences. Nevertheless, we present data from a large, diverse patient population that gives some insight into current national trends for reconstruction of the radiated breast.
CONCLUSIONS
Our study demonstrates that across the nation, immediate implant reconstruction has increased among patients who require postmastectomy radiation therapy. These findings likely reflect a changing attitude towards implant reconstruction in the setting of radiation therapy. Given the large number of radiated patients who are undergoing this procedure, and the relatively limited data on the broader community, there is room for significant inquiry into complications, cosmetic outcomes, patient satisfaction, quality of life, and the economic impact of varying reconstructive approaches. The latter is particularly interesting, because providers may soon be forced to limit and share total spending for the management of patient conditions, such as breast cancer.
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